Research News

A new role for exosomes in type 2 diabetes

2. 11. 2017 | In healthy people, a type of exosomes – tiny structures secreted by cells to allow intercellular communication – prevent clumping of a protein that leads to type 2 diabetes. In patients with the disease, these vesicles don’t have the same ability. These are the results of a new study by AcademiaNet member Professor Pernilla Wittung Stafshede.
Professor Pernilla Wittung Stafshede
Bild vergrößern
(© Anna-Lena Lundqvist )

Professor Pernilla Wittung Stafshede

Proteins are the cell’s workhorses. These macromolecules are made up of long chains of amino acids which fold into specific three-dimensional structures. Sometimes, however, they fold incorrectly and aggregate into long fibres called amyloids. Once the amyloids accumulate, they can cause diseases. This happens, for example, in the brains of people with Alzheimer's (which develop amyloid plaques). Protein aggregation can also cause diabetes type 2, which is characterised by a deposition of islet amyloid polypeptide (IAPP) in the pancreas. Now, a team of scientists led by Professor Pernilla Wittung Stafshede has unearthed a previously unknown role of exosomes in the development of the disease.

“What we’ve found is that exosomes secreted by the cells in the pancreas stop that process in healthy people and protect them from type 2 diabetes, while the exosomes of diabetes patients do not,” says Professor Wittung Stafshede. What the study shows is that “healthy” exosomes bind the protein that causes diabetes on the outside, preventing it from aggregating. However, the results do not explain why. We also don’t know if type 2 diabetes is caused by “sick” exosomes or if the disease itself causes them to malfunction.

“The next step is to make controlled models of the exosomes, whose membranes contain lipids and proteins, to understand exactly what component affects the diabetes protein. If we can find which lipid or protein in the exosome membrane leads to that effect, and can work out the mechanism.”

The study is actually a part of industrial doctoral student Diana Ribeiro’s thesis work, and a collaboration between Chalmers University and the pharmaceutical company Astrazeneca.

“She [Ribeiro] came up with the idea for the project herself,” says Prof Wittung Stafshede, who is Ribeiro’s academic advisor at Chalmers. “She had done some research on exosomes before and I had read a bit about their potential. It’s a fairly new and unexplored field, and honestly I didn’t think the experiments would work. Diana had access to pancreatic cells through Astrazeneca – something we’d never had access to before – and she conducted the studies very thoroughly, and this led us to our discovery.”

  (© Christian Borg / AcademiaNet)

More information

Original article



  1. Read what our members say about AcademiaNet.

No more excuses!

  1. Please download the brochure "No more excuses" and read more about female experts in Europe, and about AcademiaNet.


  1. Two AcademiaNet members backed to bring research findings to the market

    In a second round, the European Research Council has awarded top-up funding to fifty ERC grant holders via its Proof of Concept Grants, to explore the commercial or societal potential of their ERC-funded frontier research results. The grants are part of the EU's research and innovation programme, Horizon 2020.

  2. What the Nobels are — and aren’t — doing to encourage diversity

    The prize-awarding academies are making changes to their secretive nomination processes to tackle bias, but some say the measures don’t go far enough.

  3. Say "Yes" to Democracy

    Interview with AcademiaNet member Prof. Dr. Nicole Deitelhoff

  4. Tais Gorkhover wins LCLS Young Investigator Award for pioneering novel X-ray imaging methods

    The early-career award honours AcademiaNet member and promising leader in X-ray free-electron laser research

  5. World’s Largest Computing Association Appoints First Woman CEO

    ACM President Vicki L. Hanson takes top staff position